Código QR

Cardio-Vasculo-Renal Benefits of SGLT2 Inhibitors in Heart Failure: A Retrospective Study from a Lower-Resource Tertiary Center

<i>Background and Objectives:</i> Heart failure frequently coexists with CKD, compounding prognosis via cardio-renal interplay. Sodium glucose cotransporter 2 (SGLT2) inhibitors have demonstrated cardiovascular and renal benefits in randomized trials, but data remain limited in real-world lower-reso...

Descrición completa

Gardado en:
Principais autores: Olivia-Maria Bodea, Gabriel Florin Răzvan Mogoș, Nilima Rajpal Kundnani, Abhinav Sharma, Ovidiu Adam, Daniel Marius Duda-Seiman, Dana Velimirovici, Marioara Nicula-Neagu, Ovidiu Horea Bedreag, Simona Dragan
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2026-01-01
Series:Medicina
Assuntos:
SGLT2i
eGFR
kidney function
treatment algorithms
glycemic control
Acceso en liña:https://www.mdpi.com/1648-9144/62/2/256
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares